PSME3 and neoplasm: In the tumour immune microenvironment, proteasome activation factor PA28γ could activate the NF‐ĸB signalling pathway of oral squamous carcinoma (OSCC) cells and enhance the expression of CCL2, which promote tumour angiogenesis and reduce the survival rate.28